Ventria Bioscience Company Profile

Ventria Bioscience, headquartered in Sacramento, California, is uniquely positioned to become a scientific leader in the biopharmaceutical industry. We are dedicated to developing and producing innovative, high value products that enhance and save lives.
We have achieved scientific excellence through internal research and development and collaborations with world-renowned biotech and industry leaders. Together we have created a rich product pipeline with innovative products in human nutrition and human therapeutics. The market for these products exceeds $2 billion annually.
In 1997, Ventria's scientists developed a breakthrough protein expression technology with unrivaled efficiency. This proprietary technology platform is called ExpressTec. ExpressTec's cost-efficiency and proven commercial scalability make it possible for Ventria to address unmet and underserved needs in human and animal health by delivering affordable treatments on a global scale.
Location
4110 N. Freeway Blvd
Sacramento
California
95834
United States of America
Contact
Phone: (916) 921-6148
Fax: (916) 921-5611
Email: info@ventria.com
News Articles
Ventria Bioscience Acquires Meristem Therapeutics’ Recombinant Lactoferrin Intellectual Property
Ventria Bioscience announces the completion of an agreement under which Ventria Bioscience will wholly acquire portions of the intellectual property portfolio relating to Recombin...
Is Opposition to Genetic Engineering Moral?
National Review Online - ...by an emerging biotech company, Ventria Bioscience, those numbers could become a relic of the past, ... The solution (literally and figuratively) may be an ingenious, affor...
Ventria Bioscience and University of Colorado at Denver Awarded Grant
FORT COLLINS, Colo., Sep 04, 2012 (BUSINESS WIRE) -- Ventria Bioscience has received notification of funding for a research proposal submitted in collaboration with researchers at the University of Co...
[Meristem] licenses [Ventria] rights to recombinant human lactoferrin
French firm [Meristem Therapeutics SA] has licensed private biotech [Ventria Bioscience] exclusive rights in the US, France, and Canada to intellectual property associated with recombinant human lacto...
Ventria Bioscience has received notification of funding for a research proposal submitted in collaboration with researchers at the University of Colorado at Denver’s Skag...
The National Institutes of Health has awarded a Small Business Innovation Research (SBIR) grant to Ventria Bioscience and the University of Southern California (USC), with the...
A study comparing the in vivo receptor-binding and iron transport characteristics of Ventria Bioscience’s Optiferrin™ recombinant human transferrin (rhTF) to native, serum-der...
NIAAA funds for Acetaminophen overdose-induced liver failure treatment study
National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism (NIAAA) has funded a 1-year grant to Ventria Bioscience and University of Colorado to study treatment of an Acetamino...
Drugs and Medications
Abraxane [Abraxis BioScience, LLC]
These highlights do not include all the information needed to use ABRAXANE safely and effectively. See full prescribing information for ABRAXANE ABRAXANE® for Injectable Suspension (paclitaxel protei...
Idkit hp one [Exalenz Bioscience Ltd.]
Package Insert IDkit:Hp™ for the Exalenz BreathID® System BREATH TEST FOR DETECTION of H. pylori
PubMed Articles
Orphan technology: Unfunded early-stage bioscience is dropped off at the firehouse.
Video Q&A: Non-coding RNAs and eukaryotic evolution - a personal view.
:
CEE-ing is believing: Bioscience ventures in Central and Eastern Europe.
Bioscience ventures in Central and Eastern Europe are becoming a presence in world healthcare markets despite a perennially short supply of venture funding and other support mechanisms relative to oth...
Use of an Antifungal Drug, Amphotericin B for Isolation of Thraustochytrids.
The inhibitory effect of amphotericin B (AMPH) on the growth of fungi during the isolation of thraustochytrids was examined. The growth of fungi was significantly inhibited by addition of AMPH, and th...
Clinical Trials
Skin Safety Profile of Different Exposure to the Light Emitting Diode (LED) in Healthy Subjects
Photomodulation is a process which manipulates or regulates cell activity using light sources without thermal effect. Different studies have investigated the use of non-thermal low dose li...
Companies
Ventria Bioscience, headquartered in Sacramento, California, is uniquely positioned to become a scientific leader in the biopharmaceutical industry. We are dedicated to developing and producing innova...
InVitria is a division of Ventria Bioscience, a privately held company committed to creating innovative products enabled by advancements in biotechnology. Ventria has developed a novel animal-free pro...
The Idaho Bioscience Association
The Idaho Bioscience Association is a non-profit organization that brings together corporate, academic and political leaders to educate the public and to promote bioscience activities in the state. B...
Bioscience Bridge, LLC is a global technology transfer agency. We accelerate the connections of university-based bioscience research with commercial development opportunities. We are unique because we...
Target BioScience AG is a consulting firm focused exclusively on the pharmaceutical and biotechnology fields. Our trademark is our highly practical approach. Target BioScience AG was originally founde...
More Information about "Ventria Bioscience" on BioPortfolio
We have published hundreds of Ventria Bioscience news stories on BioPortfolio along with dozens of Ventria Bioscience Clinical Trials and PubMed Articles about Ventria Bioscience for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ventria Bioscience Companies in our database. You can also find out about relevant Ventria Bioscience Drugs and Medications on this site too.